Addition of nucleoside analogues to peg-IFNα-2a enhances virological response in chronic hepatitis B patients without early response to peg-IFNα-2a: a randomized controlled trial

Peer Review reports

Original Submission
26 Jan 2017	Submitted	Original manuscript
5 Feb 2017	Reviewed	Reviewer Report - Mar Riveiro-Barciela
14 Feb 2017	Reviewed	Reviewer Report - Etem Alhan
12 Mar 2017	Author responded	Author comments - yan xu
Resubmission - Version 2
12 Mar 2017	Submitted	Manuscript version 2
6 Apr 2017	Author responded	Author comments - yan xu
Resubmission - Version 3
6 Apr 2017	Submitted	Manuscript version 3
17 Apr 2017	Author responded	Author comments - yan xu
Resubmission - Version 4
17 Apr 2017	Submitted	Manuscript version 4
Publishing
17 Aug 2017	Editorially accepted
30 Aug 2017	Article published	10.1186/s12876-017-0657-y

Back to article page